EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

What is next? Management following endoscopic resection of barrett neoplasia - Controversies and shifting paradigms

Laura S Boer, Bas L A M Weusten, Roos E Pouw

Best Practice & Research Clinical Gastroenterology · 2026

DOI: 10.1016/j.bpg.2026.102099 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Best Practice & Research Clinical Gastroenterology, 2026. Verfasst von Laura S Boer und 2 weiteren Autor:innen. Beteiligte Einrichtung: Dept. of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Dept. of Gastroenterology …. Hauptthemen laut MEDLINE: Barrett Esophagus, Esophageal Neoplasms, Adenocarcinoma, Esophagoscopy. Die Arbeit nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Endoscopic resection (ER) is recommended for patients with a visible lesion in Barrett esophagus containing low-grade dysplasia, high-grade dysplasia, or T1 esophageal adenocarcinoma (EAC). ER is considered curative if the resection margins are free from neoplasia and no high-risk histological features, such as deep submucosal invasion, (lympho)vascular invasion, or poor tumour differentiation, are present. Subsequent ablation of the remaining Barrett segment is typically advised to prevent development of metachronous neoplasia. However, in a subset of patients, histopathology may reveal vertical tumour-positive resection margins or high-risk features of EAC. In such cases, management options traditionally involved esophagectomy and/or ((neo)adjuvant) chemo/radiotherapy due to the risk of local recurrence and lymph node metastasis, but strict endoscopic follow-up is increasingly being recognized as alternative approach. This review explores current evidence, controversies, and evolving strategies in the management following an ER for Barrett-related neoplasia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Barrett EsophagusEsophageal NeoplasmsAdenocarcinomaEsophagoscopyEsophagectomyHumansMargins of ExcisionNeoplasm Recurrence, LocalTreatment Outcome

Stichwörter der Autor:innen

(MESH or index medicus)Barrett esophagusEndoscopic ablationEndoscopic resectionEndoscopic surveillanceHigh-risk esophageal adenocarcinoma

Autor:innen und Institutionen

  • Dept. of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Dept. of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, the Netherlands. El…
  • Dept. of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands; Dept. of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, the Netherlands.
  • Dept. of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht University, Utrecht, the Netherlands.

Zitieren

APA

Boer, L. S., Weusten, B. L. A. M., & Pouw, R. E. (2026). What is next? Management following endoscopic resection of barrett neoplasia - Controversies and shifting paradigms. Best Practice & Research Clinical Gastroenterology. https://doi.org/10.1016/j.bpg.2026.102099

Vancouver

Boer LS, Weusten BLAM, Pouw RE. What is next? Management following endoscopic resection of barrett neoplasia - Controversies and shifting paradigms. Best Practice & Research Clinical Gastroenterology. 2026. doi:10.1016/j.bpg.2026.102099

BibTeX
@article{Boer2026,
  author = {Boer, Laura S and Weusten, Bas L A M and Pouw, Roos E},
  title = {What is next? Management following endoscopic resection of barrett neoplasia - Controversies and shifting paradigms},
  journal = {Best Practice & Research Clinical Gastroenterology},
  year = {2026},
  doi = {10.1016/j.bpg.2026.102099}
}
Kostenlos starten →